Crafting the blueprint for pharmaceutical advancements with the Client in mind.
See Our Services
With 35 years experience in clinical research of which 25 spent in pharmaceutical industry and a dynamic lead in clinical development regulatory strategy, Ruben Giorgino, M.D. Ph.D., the founder of Triallism GmbH, stands as an ambassador of innovation in the pharmaceutical landscape.
His expertise spans oncology, genetic metabolic disorders, and specialized therapeutics, underscored by a firm commitment to excellence. Ruben specializes in establishing challenging regulatory routes while creating integrated clinical development plans. His strategic skills are critical in bringing innovative medicines from concept to reality to address global healthcare challenges.
Industry Veteran
35-year clinical research background and over 25 years of leadership in clinical development.
Only knowledge counts
Deep knowledge across several therapeutic areas including, but not limited to, genetic metabolic disorders, oncology, and specialized therapeutics.
Above and beyond
Undisputed commitment to excellence in driving innovative drug development.
Instead of scattered individual services, we offer a centralized hub of pharmaceutical expertise
